Collegium Pharmaceutical, Inc
COLL· Nasdaq
COLLCollegium Pharmaceutical, Inc
Filed Nov 10, 2016 · 10-Q · 41 days after period end · 0001558370-16-009927
| Metric | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|
| Revenue | $408.00K | — | — |
| Net Income | -$26.44M | -$9.36M | -$6.56M |
| EPS Diluted | -$1.13 | -$0.46 | -$7.85 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Collegium Pharmaceutical, Inc · CIK 1267565 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 10, 2016 · 41 d after period end
